OROPHARYNGEAL SQUAMOUS CELL CARCINOMA

This adverse event was reported 144 times

OROPHARYNGEAL SQUAMOUS CELL CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CARMUSTINE 6 0.0013
1 DACARBAZINE 5 0.0007
2 TESAMORELIN 1 0.0006
3 PAMIDRONATE DISODIUM 2 0.0006
4 BLEOMYCIN SULFATE 6 0.0006
5 DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE 1 0.0006
6 ANTI-THYMOCYTE GLOBULIN (RABBIT) 3 0.0004
7 CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE 1 0.0003
8 BUSPIRONE HYDROCHLORIDE 3 0.0003
9 ATOVAQUONE 2 0.0002
See all drugs enriched for association with OROPHARYNGEAL SQUAMOUS CELL CARCINOMA